PATENT CLAIM ANALYSIS

Application Number: 16075528
Application Type: Utility
Filing Date: 2018-08
Publication Date: 2019-02
Patent Classification: ["514", "560000"]

Abstract:
The present invention relates to a class of fatty acid compounds, a preparation method thereof and use thereof. The fatty acid compounds have the structure of the formula I, which has the ability to activate APMK and inhibit the glucose output in mouse primary hepatocytes. The fatty acid compounds can be used in preparing a medicament for the treatment of obesity or diabetes.

Claim (Index 14):
A pharmaceutical composition for treating obesity or diabetes, comprising:\n one or more compounds selected from the group consisting of the fatty acid compound and pharmaceutically acceptable salts thereof according to  claim 1  as an active ingredient; and one or more pharmaceutically acceptable carrier.

Metadata:
- Claim Count in Document: 6.0
- Percentile: 96.0
- Lexical Diversity: 1.51111
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['15326310', '15109101', '14398643', '15505052', '09972743']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7708338736826511
- 35 USC 102 Novelty (BERT): 0.5199393038255186
- Combined Prediction Score: 0.7457444166969378
- Mean Citation Score: 300.82333
- Max Citation Score: 318.17914
- Similarity Product: 220.98884917276504

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test